Maximising Patient Engagement in Clinical Trials
Clinically Validated Probiotics
The Emergence of 3D Printing in Expanding Clinical Research and Pharmaceutical Compounding
Could a Formal Trust Coefficient Release the Pharmacovigilance Capacity AI Promised
Why Sustainable Biomanufacturing Must Start Earlier in The Process
EDITORIAL SECTIONS
RESEARCH & DEVELOPMENT
Adopting the Power of AI to Drug Development Projects
A tremendous amount of documentation is created throughout the clinical trial lifecycle
CLINICAL TRIALS
Real-world Evidence
Hearing the diagnosis from the doctor that your child has spinal muscular atrophy SMA
MANUFACTURING
Just in Time Manufacturing Creating more sustainable supply chains
Drug development has transformed immeasurably over the past decade Even before the Covid pandemic and the conflict in Ukraine
Information Technology
Challenges and Advantages of Using Artificial Intelligence in Pharma
Many advanced largescale AI initiatives still need to be proved successful in Pharma
KNOWLEDGE BANK
Interviews
Datamonitor
Analyst
include the changing patent laws as countries aim to become more TRIPS compliant with India updating its law recently and China in the process of doing so through the WTO Increasing globalization of the generics market with Indian companies becoming involved in Europe and the US and vice versa will also provide an opportunity for generics companies
Articles
Tiny Vesicles, Big Impact
Exosomes have emerged as a promising area of research with significant potential in drug delivery and diagnosis in cancer These tiny particles previously regarded as cellular waste are now acknowledged for their crucial function in intercellular communication and their ability to transport molecular cargo such as nucleic acids and proteins
Research Insights
Distribution Of Bacterial Contamination In Non-sterile Pharmaceutical Materials And Assessment Of Its Risk To The Health Of The Final Consumers Quantitatively
Abstract Bacterial contamination control in pharmaceutical products is a critical aspect in the field of drug manufacturing industry due to the encountered risk to the patients health and possibly their life The application of commercial bacterial identification system is crucial to identify the type of contamination and its source to anticipate the impac
Case Studies
Case Study: A Simple And Sensitive Method To Analyze Genotoxic Impurityhydrazine In Pharmaceutical Materials
Abstract Hydrazine NH is a known genotoxic impurity that typically needs to be controlled down to low ppm level in pharmaceutical development Hydrazine however is a challenging molecule to analyze using conventional analytical techniques due to its physical and chemical properties eg lack of chromophore absence of any carbon atom low molecular weigh
Techno Trends
Johnson & Johnson Introduces Breakthrough TAR-200 Therapy for Non-Muscle-Invasive Bladder Cancer
Johnson Johnson has unveiled TAR therapy aimed at potentially treating individuals diagnosed with highrisk nonmuscleinvasive bladder cancer that doesnt respond to Bacillus CalmetteGurin treatment
White Papers
Cloud Computing in the Laboratory Informatics Solutions and Validation Approaches
In the modern business environment, a significant portion of work is conducted using computerized systems. Many solutions are used to complete tasks, including simple desktop programs like email and Microsoft Office to enterprise-wide, global systems like ERP (Enterprise Resource Planning), MES (Manufacturing Execution System), and LIMS
TOP ARTICLES
The Role of Technology in Continued Process Verification 4.0
Dr. Kavita is a seasoned leader in the field of data and insights, with over 20 years of invaluable experience. She is a result-oriented solution designer in data warehouse and big data analytics. Drawing from her extensive in multinational organisations IBM, Capgemini, and others, Kavita has successfully overseen numerous large and intricate projects. Her expertise lies in effectively leveraging her robust technical knowledge in areas such as data warehousing and business intelligence to drive impactful outcomes. Under Dr. Kavita's exceptional leadership, the CaliberAPQR product has achieved outstanding recognition.
The Role of Bioinformatics in Accelerating Translational Research
Vasundhara Dauneria is a biotechnology professional with over six years of experience spanning genomics, next-generation sequencing, and bioinformatics. She has worked across wet-lab and computational research environments, with hands-on expertise in NGS workflows, assay development, and multi-omics data analysis. Her work focuses on applying data-driven approaches to support translational research and precision medicine initiatives.
Applying Human Factors Engineering to Generic Combination Products
Frauke Schuurkamp has 12 years of experience delivering HFE services to the medical and pharmaceutical industries. Schuurkamp conducts HFE workshops, advises on HFE strategies, leads research and analysis activities and develops key deliverables to support FDA and international regulatory submissions. Schuurkamp holds a bachelor’s degree in applied psychology and a master’s degree in human factors psychology.
Lisanne de Vogel has 7+ years of experience delivering HFE services to the medical device and pharmaceutical industries. Lisanne leads and oversees human factors research activities, such as usability testing, and helps clients develop key HFE documents for their (international) regulatory submissions, as well as advising them on how to apply HFE during product development to meet regulators' expectations. She holds a bachelor’s degree in Communication Science and a master’s degree in Applied Cognitive Psychology.
3D Printing Revolutionising Nanotechnology
Mansi Athalye is Assistant Professor in Department of Pharmaceutics at L. M. College of Pharmacy, India with approx. 10 years of teaching and research experience. She has published 12 papers in international and national journals and has presented 22 papers in various conferences as author and co-author with 1 Indian Patent granted in 2018.
Sagar Popat is research student pursuing M. Pharmacy in Pharmaceutics at L. M. College of Pharmacy. He has worked on the topic ‘Cataract of goat eye lens by Invitro and Ex-vivo method’. He has published 1 research article and has won 1st prize in oral presentation at national level conference.
Industry 4.0 at Bachem
Elodie Decuypere received her Ph.D in Organic Synthesis from the University of Paris-Saclay with specialization in Click Chemistry. After her Ph.D, Elodie specialized in oligonucleotide chemistry with her two postdoc in ETH Zürich and Roche Basel. In 2020, Elodie joined Bachem as a Specialist Marketing and works on the creation of scientific content for marketing materials.
press releasesRead more...
Foresee Pharmaceuticals Announces China NMPA Approval of CAMCEVI® 42 mg for the Treatment of Advanced Prostate Cancer; Changchun GeneScience Pharmaceutical will Commercialize in China
Foresee Pharmaceuticals announced that it was notified by its licensing partner Changchun GeneScience Pharmaceutical Co Ltd GenSci that Chinas National Medical Products Administration NMPA has approved the Marketing Authorization Application MAA for CAMCEVI mg a readytouse month subcutaneous depot...
Expert Shares How to Avoid Common Pitfalls in Preclinical Development
Behind every drug that reaches patients is a preclinical programme that most people never see Getting it right can be the difference between a molecule that moves smoothly into the clinic and one that stalls before it gets there Preclinical development brings together pharmacology toxicology formula...
BioAgilytix Expands Global Bioanalytical Capabilities with New Sydney Laboratory
BioAgilytix a global leader in bioanalytical services announces the opening of a new laboratory in North Ryde Sydney through biolabs its Australian laboratory business The expansion extends BioAgilytixs bioanalytical footprint across Australia Europe and the United States
Insitro Designed Machine Learning Models for Small Molecule in vivo Pharmacokinetic Behavior Prediction Now Available in Lilly TuneLab
Insitro the AI company unlocking causal human biology to systematically generate highimpact therapeutics today announced that the advanced machine learning models that insitro built with Eli Lilly
Lotus Pharmaceutical Announces Completion of UroVaxom® Product Rights Acquisition in South Korea
Lotus Pharmaceutical Co Ltd Taiwan Stock Exchange a global pharmaceutical company headquartered in Taiwan today announced the completion of the acquisition of the South Korea product rights
XtalPi Debuts Kodexia™, the World's First Closed-Loop siRNA Platform Combining Generative AI with First-Principles Modeling
XtalPi Holdings Limited HKEX an AI and roboticsdriven drug and materials discovery company today debuted Kodexia the industrys first closedloop small interfering RNA siRNA
EventsRead more...
14 - 15
Oct 2026PDA Aseptic Manufacturing Excellence Conference
Pullman East Melbourne, Austra...
21 - 23
Oct 2026Drug Formulation & Drug Delivery 2026
Paris, France
21 - 22
Oct 2026Advance Clinical Trials and Research 2026
Paris, France
22 - 23
Oct 2026PDA Aseptic Symposium 2026
Congress Square Nakanoshima, O...
26 - 28
Oct 2026ACHEMA Middle East 2026
RICEC, Riyadh, KSA, Saudi Arab...
26 - 28
Oct 2026World Orphan Drug Congress
RAI, Amsterdam, Netherlands
27 - 28
Oct 2026PM& AC 2026
Novotel Hyderabad Convention C...
28 - 30
Oct 2026BIOPLUS-INTERPHEX KOREA 2026
COEX, Seoul
LATEST NEWSRead more...
InnoCare Announces Approval of Clinical Trial of Bispecific Antibody ICP-B161 Targeting TL1A and IL-23p19 in China
InnoCare Pharma a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases announced today that the Center for Drug Evaluation CDE of Chinas National Medical Products Administration NMPA has approved its Investigational New Drug IND application for ICPB a bispeci...
Mint Pharmaceuticals and Bayer Expand Medicine Distribution in Canada
Mint Pharmaceuticals and Bayer have expanded their distribution partnership in Canada to include several additional medicines across womens health cardiovascular care and anticoagulation
Halozyme Expands argenx Collaboration to Include Two Additional Development Targets
Halozyme Therapeutics has expanded its global collaboration and licence agreement with argenx to develop and commercialise subcutaneous formulations for two additional exclusive targets using its ENHANZE drug delivery technology
CSL and Alentis Partner to Advance Lixudebart for Rare Kidney and Liver Diseases
CSL and Alentis Therapeutics have entered into a global collaboration to jointly develop and commercialise lixudebart an investigational treatment that targets claudin and could have applications across several kidney liver and other diseases
Regeneron and Sanofi Expand Collaboration to Develop Long-Acting Immunology Antibodies
Regeneron Pharmaceuticals and Sanofi have expanded their longstanding antibody collaboration to develop and commercialise a new group of longacting immunology treatments
SK pharmteco Announces $200 Million Investment to Expand Manufacturing Capacity
SK pharmteco has announced a fiveyear investment of more than million to expand and upgrade its development and manufacturing capabilities in the US focusing on small molecules and peptides
